论文部分内容阅读
1861年Fischer首次报告了硫酸软骨素,1891年Schmiedebery从鼻软骨中分离硫酸软素骨成功。一百多年来,硫酸软骨素的理化性质逐渐清楚,尤其近年来,逐渐明确硫酸软骨素所具有的生理功能,能调节体内阳离子浓度;防御细菌感染;调节骨胶原纤维的合成;净化高脂肪血,以及软骨的化骨化、石炭化等。总之,硫酸软骨素在维持组织和免疫机能上起着重要作用。目前临床上,硫酸软骨素作为药物治疗肾炎、急、慢性肝炎、神经痛、关节痛、
Fischer first reported chondroitin sulfate in 1861 and in 1891 Schmiedebery succeeded in isolating sulphate from nasal cartilage. More than one hundred years, the physical and chemical properties of chondroitin sulfate gradually become clear, especially in recent years, gradually clear the physiological function of chondroitin sulfate, can regulate the concentration of cations in the body; to prevent bacterial infection; regulate the synthesis of collagen fibers; Blood, and cartilage ossification, such as carbonization. In conclusion, chondroitin sulfate plays an important role in maintaining tissue and immune function. Currently clinically, chondroitin sulfate as a drug treatment of nephritis, acute and chronic hepatitis, neuralgia, joint pain,